129 related articles for article (PubMed ID: 32227927)
21. Translocation of 5' mRNA cap analogue--peptide conjugates across the membranes of giant unilamellar vesicles.
Worch R; Piecyk K; Kolasa AB; Jankowska-Anyszka M
Biochim Biophys Acta; 2016 Feb; 1858(2):311-7. PubMed ID: 26654783
[TBL] [Abstract][Full Text] [Related]
22. Biophysical approach to studies of cap-eIF4E interaction by synthetic cap analogs.
Niedzwiecka A; Stepinski J; Antosiewicz JM; Darzynkiewicz E; Stolarski R
Methods Enzymol; 2007; 430():209-45. PubMed ID: 17913640
[TBL] [Abstract][Full Text] [Related]
23. Regulation of cap-dependent translation by eIF4E inhibitory proteins.
Richter JD; Sonenberg N
Nature; 2005 Feb; 433(7025):477-80. PubMed ID: 15690031
[TBL] [Abstract][Full Text] [Related]
24. Phosphorothioate analogs of m7GTP are enzymatically stable inhibitors of cap-dependent translation.
Kowalska J; Lukaszewicz M; Zuberek J; Ziemniak M; Darzynkiewicz E; Jemielity J
Bioorg Med Chem Lett; 2009 Apr; 19(7):1921-5. PubMed ID: 19269171
[TBL] [Abstract][Full Text] [Related]
25. Tracking the m
Gross L; Schaeffer L; Alghoul F; Hayek H; Allmang C; Eriani G; Martin F
Methods; 2018 Mar; 137():3-10. PubMed ID: 29307728
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of HIV-1 transcription and virus replication using soluble Tat peptide analogs.
Kashanchi F; Sadaie MR; Brady JN
Virology; 1997 Jan; 227(2):431-8. PubMed ID: 9018142
[TBL] [Abstract][Full Text] [Related]
27. Interaction of three Caenorhabditis elegans isoforms of translation initiation factor eIF4E with mono- and trimethylated mRNA 5' cap analogues.
Stachelska A; Wieczorek Z; Ruszczyńska K; Stolarski R; Pietrzak M; Lamphear BJ; Rhoads RE; Darzynkiewicz E; Jankowska-Anyszka M
Acta Biochim Pol; 2002; 49(3):671-82. PubMed ID: 12422237
[TBL] [Abstract][Full Text] [Related]
28. Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma.
Demosthenous C; Han JJ; Stenson MJ; Maurer MJ; Wellik LE; Link B; Hege K; Dogan A; Sotomayor E; Witzig T; Gupta M
Oncotarget; 2015 Apr; 6(11):9488-501. PubMed ID: 25839159
[TBL] [Abstract][Full Text] [Related]
29. The C-terminal domain of eukaryotic protein synthesis initiation factor (eIF) 4G is sufficient to support cap-independent translation in the absence of eIF4E.
Ohlmann T; Rau M; Pain VM; Morley SJ
EMBO J; 1996 Mar; 15(6):1371-82. PubMed ID: 8635470
[TBL] [Abstract][Full Text] [Related]
30. Nucleotide-decorated AuNPs as probes for nucleotide-binding proteins.
Perzanowska O; Majewski M; Strenkowska M; Głowala P; Czarnocki-Cieciura M; Mazur M; Kowalska J; Jemielity J
Sci Rep; 2021 Aug; 11(1):15741. PubMed ID: 34344911
[TBL] [Abstract][Full Text] [Related]
31. Thermodynamics of cell-penetrating HIV1 TAT peptide insertion into PC/PS/CHOL model bilayers through transmembrane pores: the roles of cholesterol and anionic lipids.
Hu Y; Patel S
Soft Matter; 2016 Aug; 12(32):6716-27. PubMed ID: 27435187
[TBL] [Abstract][Full Text] [Related]
32. Influenza virus mRNA translation revisited: is the eIF4E cap-binding factor required for viral mRNA translation?
Burgui I; Yángüez E; Sonenberg N; Nieto A
J Virol; 2007 Nov; 81(22):12427-38. PubMed ID: 17855553
[TBL] [Abstract][Full Text] [Related]
33. Functional Cyclization of Eukaryotic mRNAs.
Alekhina OM; Terenin IM; Dmitriev SE; Vassilenko KS
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32121426
[TBL] [Abstract][Full Text] [Related]
34. A fluorescence spectroscopic study on the binding of mRNA 5'-cap-analogs to human translation initiation factor eIF4E: a critical evaluation of the sources of error.
Wieczorek Z; Darzynkiewicz E; Lönnberg H
J Photochem Photobiol B; 1998 May; 43(2):158-63. PubMed ID: 9679316
[TBL] [Abstract][Full Text] [Related]
35. Eukaryotic translation initiation factor 4E availability controls the switch between cap-dependent and internal ribosomal entry site-mediated translation.
Svitkin YV; Herdy B; Costa-Mattioli M; Gingras AC; Raught B; Sonenberg N
Mol Cell Biol; 2005 Dec; 25(23):10556-65. PubMed ID: 16287867
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of platelet activation by peptide analogs of the beta(3)-intracellular domain of platelet integrin alpha(IIb)beta(3) conjugated to the cell-penetrating peptide Tat(48-60).
Dimitriou AA; Stathopoulos P; Mitsios JV; Sakarellos-Daitsiotis M; Goudevenos J; Tsikaris V; Tselepis AD
Platelets; 2009 Dec; 20(8):539-47. PubMed ID: 19863457
[TBL] [Abstract][Full Text] [Related]
37. Potential therapeutic applications of RNA cap analogs.
Ziemniak M; Strenkowska M; Kowalska J; Jemielity J
Future Med Chem; 2013 Jun; 5(10):1141-72. PubMed ID: 23795970
[TBL] [Abstract][Full Text] [Related]
38. Cap-dependent translation initiation in eukaryotes is regulated by a molecular mimic of eIF4G.
Marcotrigiano J; Gingras AC; Sonenberg N; Burley SK
Mol Cell; 1999 Jun; 3(6):707-16. PubMed ID: 10394359
[TBL] [Abstract][Full Text] [Related]
39. Eukaryotic translation initiation is controlled by cooperativity effects within ternary complexes of 4E-BP1, eIF4E, and the mRNA 5' cap.
Modrak-Wojcik A; Gorka M; Niedzwiecka K; Zdanowski K; Zuberek J; Niedzwiecka A; Stolarski R
FEBS Lett; 2013 Dec; 587(24):3928-34. PubMed ID: 24211447
[TBL] [Abstract][Full Text] [Related]
40. Influence of the length of the phosphate chain in mRNA 5' cap analogues on their interaction with eukaryotic initiation factor 4E.
Zuberek J; Jemielity J; Niedzwiecka A; Stepinski J; Wyslouch-Cieszynska A; Stolarski R; Darzynkiewicz E
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1707-10. PubMed ID: 14565501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
